key: cord-0935053-7v1f42vl authors: Teyssou, Elisa; Delagrèverie, Héloise; Visseaux, Benoit; Lambert-Niclot, Sidonie; Brichler, Ségolène; Ferre, Valentine; Marot, Stéphane; Jary, Aude; Todesco, Eve; Schnuriger, Aurélie; Ghidaoui, Emna; Abdi, Basma; Akhavan, Sepideh; Houhou-Fidouh, Nadhira; Charpentier, Charlotte; Morand-Joubert, Laurence; Boutolleau, David; Descamps, Diane; Calvez, Vincent; Marcelin, Anne; Soulie, Cathia title: The Delta SARS-CoV-2 variant has a higher viral load than the Beta and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 date: 2021-08-19 journal: J Infect DOI: 10.1016/j.jinf.2021.08.027 sha: 08f267046f8eb1d959caab5805bb4076e98425d1 doc_id: 935053 cord_uid: 7v1f42vl nan The Delta SARS-CoV-2 variant has a higher viral load than the Beta and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients Moreover, it has been established that the Delta variant presented a transmissibility 40 to 60 % higher than the Alpha variant 5 . In order to evaluate the VL of the Delta variant in France, we measured and We also observed a significant 2.5-fold higher difference in VL levels between the Delta variant and the Beta variant (median 7.26 [6.10-8.37]) (p<0.05). No statistical difference was found between the Delta and the Alpha (median 8.05 [6.13-9 .08]) variants ( Figure 1B) . Our results showed significant differences of the relative VL between the Delta and the Beta and the historical variants. Indeed, the Delta variant has statistically higher nasopharyngeal VL at diagnosis than the Beta and the historical lineages. The Alpha and Delta variants had similar VL. Further studies are required to confirm potential higher infectiousness and higher severity of the disease caused by these emerging variants. However, our study confirmed that the Delta variant presented a higher viral load, which could partially justify its rapid dominant position in France. As previously, we focused on the relative VL in one swab per patient, which could be influenced by the variation of the nasopharyngeal swab technique. To limit sampling bias, we only collected samples from initial diagnostic swabs and we assessed Ct values using the same SARS-CoV-2 assay. We also collected samples during a variant specific target timing: we collected samples for each variant during their emergence phase. We did not observe such a huge VL difference between the Delta variant and the historical variants as the one observed with the 19A/19B lineage 4 . However, this difference can be explained by the fact that all the historical variants studied here presented the D614G mutation, absent from the 19A/19B lineages, which is known to confer a better infectivity to the virus 6 . Unlike the Alpha and the Beta variants, the Delta variant does not harbour the N501Y mutation in the Spike (S) protein which is known in the Alpha variant to enhance the affinity for ACE2 7 . However, the Delta variant carries three key S mutations, L452R, T478K and P681R which confer resistance to some neutralizing monoclonal antibodies and a possibly higher transmission 8 . Indeed, it has been shown that the L452R mutation leads to increased infectivity, though slightly lower than with the N501Y mutation, compared to historical lineages 9 . Moreover, the L452R and the T478K possibly increase ACE2 binding and the stabilization of the ACE2-RBD complex and the P681R, present in the furin cleavage site, could enhance the transmissibility of the virus by its action on the S1-S2 cleavage 10 . These mutations confer equally to the virus a resistance to neutralizing monoclonal antibodies by disrupting their binding ability to the RBD spike 10 and could play a role in vaccine escape, which could explain its worldwide predominance. Overall, our study brings evidence of increased infectivity of the Delta variant that could contribute to its fast worldwide propagation. The authors declare that they have no conflict of interest. Introduction of the South African SARS-CoV-2 variant 501Y.V2 into the UK The 501Y.V2 SARS-CoV-2 variant has an intermediate viral load between the 501Y.V1 and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients Centers for Disease Control and Prevention Viral infection and transmission in a large well-traced outbreak caused by the Delta SARS-CoV-2 variant -SARS-CoV-2 coronavirus / nCoV-2019 Genomic Epidemiology The D614G mutations in the SARS-CoV-2 spike protein: Implications for viral infectivity, disease severity and vaccine design SARS-CoV-2 Variants with a Focus at the ACE2-Spike RBD Interface The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant SARS-CoV-2 Spike Mutations, L452R, T478K, E484Q and P681R, in the Second Wave of COVID-19 in Maharashtra The authors acknowledged all the members of the Pitié-Salpêtrière, Bichat, Saint-Antoine/Trousseau and Avicenne Virology departments for their collaboration and clinicians of the four hospitals for their implication in the SARS-CoV-2 patient care.We thank the ANRS-MIE (Agence Nationale de Recherches sur le SIDA et les hépatites virales-Maladies Infectieuses Emergentes) (AC43, Medical Virology) for its support. Figure 1 : Delta variant, similarly to the Alpha variant, is associated with a higher viral load than Beta and historical SARS-CoV-2 variants.The graph presents the median and the quartiles of the relative VL in log 10 copies/ml of the four groups for the ORF1ab gene (A) and for the N gene (B). The median of the relative VL was higher for the Delta than the Beta and the historical SARS-CoV-2 variants. *p<0.05, ***p<0.001, ****p<0.0001.